Atkore's revenue growth is expected to slow down substantially, with a projected annual growth of 2.1% until 2024, compared to its historical 19% growth. This is slower than industry peers, expected to grow at 7.8% annually.
Atkore's low P/E ratio is due to its weak earnings forecast. Investors think the potential for earnings improvement doesn't justify a higher P/E ratio, hence a significant share price rise is unlikely soon.
Atkore's performance indicates the presence of ample internal investment opportunities at increasingly high rates - a trait common amongst multi-baggers. Despite one identified warning sign for Atkore, the continuity of these trends may be worth exploring for investors.
The lack of insider buying and significant selling at current market prices raises concerns. However, insider ownership does indicate some alignment with shareholder interests. No insider trading in the last quarter does not provide a strong direction for the stock.
Alphabet$Alphabet-C (GOOG.US)$keeps its spot on the Warren Buffett stock screen, but GOOGL stock has fallen off the IBD Long-Term Leaders list. Meanwhile, Microsoft$Microsoft (MSFT.US)$remains on IBD Long-Term Leaders while MSFT stock falls off the Warren Buffett screen. Building materials manufacturer Atkore$Atkore (ATKR.US)$tops the list with an impressive sustainable earnings growth rate of 90%. (The rate is computed by multiplying the company's ROE by the ear...
Gainers: •$Belite Bio (BLTE.US)$+17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1) •$Atkore (ATKR.US)$+12.11% (earnings reports) •$AST SpaceMobile (ASTS.US)$+9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing) •$Harmonic (HLIT.US)$+7.56% (earnings reports) •$The Chemours (CC.US)$+7.2% ...
Atkore Stock Forum
fail again ..
Building materials manufacturer Atkore $Atkore (ATKR.US)$ tops the list with an impressive sustainable earnings growth rate of 90%. (The rate is computed by multiplying the company's ROE by the ear...
- In the top 25% of all stocks in terms of five-year annual EPS growth rate.
- 15% or greater sustainable earnings growth.
- 12% or better five-year average return on equity.
$Warren Buffett Portfolio (LIST2999.US)$ $Berkshire Hathaway-A (BRK.A.US)$ $Berkshire Hathaway-B (BRK.B.US)$ $Atkore (ATKR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Daqo New Energy (DQ.US)$ $Lululemon Athletica (LULU.US)$ $Alphabet-C (GOOG.US)$ $Alphabet-A (GOOGL.US)$ $Triton International (TRTN.US)$ $Apple (AAPL.US)$ $Taiwan Semiconductor (TSM.US)$ $Occidental Petroleum (OXY.US)$ $Chevron (CVX.US)$
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
$Northrop Grumman (NOC.US)$ NOC: A very safe stock with upside if the space industry takes off
$Atkore (ATKR.US)$ ATKR: Dominate in the electrical field
$Continental Resources (CLR.US)$ CLR: Betting on oil prices continuing their rise due to inflation
$Robert Half (RHI.US)$ RHI: I think they will blow out earnings with how much hiring is going on, their business is booming right now
$Ultra Financials Proshares (UYG.US)$ UYG: A 2x leveraged fund that is made up of financial stocks. Inflation should lead to higher interest rates = more profits for this sector
No comment yet